Scientists at City of Hope have uncovered a gene called SMOC1 that plays a surprising role in the development of type 2 ...

For years, scientists have focused their attention on the pancreas’ insulin-producing beta cells and left small clusters of ...

Biomea Fusion, Inc. announced positive results from preclinical experiments showing that its investigational drug icovamenib enhances beta cell function and improves the responsiveness of human islets ...

Belgium: A phase 2 international trial published in The Lancet has found that low-dose antithymocyte globulin (ATG) can slow ...

Therapeutic effects were sustained off treatment, with persistent reduction in HbA1c and improvement in beta-cell function 3 months after last dose, suggesting disease-modifying potential of ...

A 2-year follow-up of the randomized, placebo-controlled BANDIT trial shows that stopping baricitinib leads to a loss of therapeutic benefit, supporting its evaluation in earlier stages of type 1 ...

Icovamenib showed a sustained treatment benefit at Week 52 (9 months past the end of treatment) in the severe insulin-deficient diabetes patient ...

Canada: Empagliflozin did not significantly preserve beta-cell function in women with a recent history of gestational ...

A new study by the University of California, Davis, shows how cells work together to avoid a sudden drop in blood sugar.